Dr Mahomed Y Salame, MD | |
1031 Quintard Ave Ste 1a, Anniston, AL 36201-5714 | |
(256) 231-2552 | |
(256) 231-2550 |
Full Name | Dr Mahomed Y Salame |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 36 Years |
Location | 1031 Quintard Ave Ste 1a, Anniston, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487625661 | NPI | - | NPPES |
051522720 | Other | AL | BCBS |
264378757 | Other | AL | CHAMPUS GROUP |
051522720 | Other | AL | BCBS GROUP |
111755 | Medicaid | AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0011X | Internal Medicine - Interventional Cardiology | 25751 (Alabama) | Secondary |
207RC0000X | Internal Medicine - Cardiovascular Disease | 25751 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Northeast Alabama Regional Medical Center | Anniston, AL | Hospital |
University Of Alabama Hospital | Birmingham, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Salame Heart And Vascular Clinic Llc | 3274683834 | 3 |
The Health Care Authority Of The City Of Anniston | 3971408923 | 24 |
News Archive
Maternal health and dengue fever are among the issues that will be discussed at the 61st session of the WHO Regional Committee for the Western Pacific, Bernama reports.
Egypt's crisis has raised alarms about national security and economic impact for Americans if regime change leads to an anti-US government controlling a strong ally in the Middle East. This crisis raises another more personal concern for Americans that has been overlooked by the national media: the security and availability of your electronic medical records in the event of a government-imposed "kill switch" for the Internet.
Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).
The mediated version of what women should look like has always been under scrutiny, particularly looking at actresses and fashion models. But what about body image from social networks and friends? A recent study by researchers in the United Kingdom and United States, found that more time on Facebook could lead to more negative feelings and more comparisons to the bodies of friends.
A successful treatment for age-related hearing loss (ARHL) is a step closer to reality, thanks to a group of researchers from the University of South Florida. The research team comprised of faculty and students has been awarded $400,000 by Autifony Therapeutics, Ltd, a company based in the United Kingdom, to test a new drug the company developed for ARHL.
› Verified 2 days ago
Entity Name | The Health Care Authority Of The City Of Anniston |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003996000 PECOS PAC ID: 3971408923 Enrollment ID: O20031203000272 |
News Archive
Maternal health and dengue fever are among the issues that will be discussed at the 61st session of the WHO Regional Committee for the Western Pacific, Bernama reports.
Egypt's crisis has raised alarms about national security and economic impact for Americans if regime change leads to an anti-US government controlling a strong ally in the Middle East. This crisis raises another more personal concern for Americans that has been overlooked by the national media: the security and availability of your electronic medical records in the event of a government-imposed "kill switch" for the Internet.
Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).
The mediated version of what women should look like has always been under scrutiny, particularly looking at actresses and fashion models. But what about body image from social networks and friends? A recent study by researchers in the United Kingdom and United States, found that more time on Facebook could lead to more negative feelings and more comparisons to the bodies of friends.
A successful treatment for age-related hearing loss (ARHL) is a step closer to reality, thanks to a group of researchers from the University of South Florida. The research team comprised of faculty and students has been awarded $400,000 by Autifony Therapeutics, Ltd, a company based in the United Kingdom, to test a new drug the company developed for ARHL.
› Verified 2 days ago
Entity Name | Salame Heart And Vascular Clinic Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437390184 PECOS PAC ID: 3274683834 Enrollment ID: O20090603000139 |
News Archive
Maternal health and dengue fever are among the issues that will be discussed at the 61st session of the WHO Regional Committee for the Western Pacific, Bernama reports.
Egypt's crisis has raised alarms about national security and economic impact for Americans if regime change leads to an anti-US government controlling a strong ally in the Middle East. This crisis raises another more personal concern for Americans that has been overlooked by the national media: the security and availability of your electronic medical records in the event of a government-imposed "kill switch" for the Internet.
Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).
The mediated version of what women should look like has always been under scrutiny, particularly looking at actresses and fashion models. But what about body image from social networks and friends? A recent study by researchers in the United Kingdom and United States, found that more time on Facebook could lead to more negative feelings and more comparisons to the bodies of friends.
A successful treatment for age-related hearing loss (ARHL) is a step closer to reality, thanks to a group of researchers from the University of South Florida. The research team comprised of faculty and students has been awarded $400,000 by Autifony Therapeutics, Ltd, a company based in the United Kingdom, to test a new drug the company developed for ARHL.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Mahomed Y Salame, MD 901 Leighton Ave, Suite 702, Anniston, AL 36207-5700 Ph: (256) 231-2552 | Dr Mahomed Y Salame, MD 1031 Quintard Ave Ste 1a, Anniston, AL 36201-5714 Ph: (256) 231-2552 |
News Archive
Maternal health and dengue fever are among the issues that will be discussed at the 61st session of the WHO Regional Committee for the Western Pacific, Bernama reports.
Egypt's crisis has raised alarms about national security and economic impact for Americans if regime change leads to an anti-US government controlling a strong ally in the Middle East. This crisis raises another more personal concern for Americans that has been overlooked by the national media: the security and availability of your electronic medical records in the event of a government-imposed "kill switch" for the Internet.
Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).
The mediated version of what women should look like has always been under scrutiny, particularly looking at actresses and fashion models. But what about body image from social networks and friends? A recent study by researchers in the United Kingdom and United States, found that more time on Facebook could lead to more negative feelings and more comparisons to the bodies of friends.
A successful treatment for age-related hearing loss (ARHL) is a step closer to reality, thanks to a group of researchers from the University of South Florida. The research team comprised of faculty and students has been awarded $400,000 by Autifony Therapeutics, Ltd, a company based in the United Kingdom, to test a new drug the company developed for ARHL.
› Verified 2 days ago
Dr. Rohit G Patel, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 901 Keith Ave, Anniston, AL 36207 Phone: 256-236-8611 Fax: 256-236-8636 | |
Venugopala S Bheemanathini, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 522 E 11th St, Suite 200, Anniston, AL 36207 Phone: 256-237-5302 Fax: 256-237-5368 | |
Vishala Chindalore, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1010 Christine Ave, Anniston, AL 36207 Phone: 256-236-5631 Fax: 256-236-5637 | |
Dr. Chidiebere Maquincy Ibekwe, M.D, MPH, FACP Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 400 E 10th St, Anniston, AL 36207 Phone: 256-235-5639 | |
Wyndol Span Hamer Jr., M.D Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1700 Christine Ave, Suite 102, Anniston, AL 36207 Phone: 256-294-7004 Fax: 256-294-7005 | |
Almena Free, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 400 E 10th St, Anniston, AL 36207 Phone: 256-236-5631 Fax: 256-236-5335 | |
Mohamed Jasser, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 901 Leighton Ave, Suite 307, Anniston, AL 36207 Phone: 256-231-8636 Fax: 256-231-8684 |